X-Linked Severe Combined Immunodeficiency (X-SCID) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
X-linked severe combined immunodeficiency (X-SCID) is a life-threatening primary immunodeficiency that manifests as a deficiency in T and B lymphocytes or impaired lymphocyte function. Infants diagnosed with this condition typically succumb to recurrent infections caused by opportunistic pathogens within the first year of life. Various abnormalities in cellular signaling have been documented, but the primary defect in X-linked SCID is the inability to produce a receptor γ-chain. This γ-chain is a crucial component of high-affinity receptors for several interleukins, including IL-2, IL-4, IL-7, IL-9, and IL-15. The activation of lymphocytes, the synthesis of diverse antibody types, TCR re-arrangements, and the development of natural killer (NK) cells all hinge on the engagement of these receptors. The IL2RG gene responsible for this deficiency is at the Xq13.1 locus, resulting in an X-linked inheritance pattern exclusively affecting males. Comprising eight exons, the IL2RG gene has...